REGENXBIO Inc. ( NASDAQ:RGNX - Free Report ) - Stock analysts at HC Wainwright increased their Q3 2026 earnings per share estimates for REGENXBIO in a ...
Minoryx is perceived as one of Valerion Therapeutics's biggest rivals. Minoryx's headquarters is in Mataro, Barcelona, and was founded in 2011. Minoryx operates in the Biotechnology industry. Minoryx generates 221% of Valerion Therapeutics's revenue.
SQZ Biotech has been one of Valerion Therapeutics's top competitors. SQZ Biotech is a Public company that was founded in 2013 in Watertown, Massachusetts. SQZ Biotech operates in the Biotechnology industry. Compared to Valerion Therapeutics, SQZ Biotech has 1,600 more employees.